Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement,... see more

GREY:CBICF - Post Discussion

The Canadian Bioceutical > MPX's deal with iAnthus
View:
Post by bogdansz on Dec 29, 2018 11:47am

MPX's deal with iAnthus

For MPX's sake, the company did not sign over its Canadian and International assets in the deal with iAnthus and those will be spun-out into a new entity, MPX International. The latter will be nothing to sneeze at as it has a licensed GMP-compliant Canadian facility (able to produce 1,200 kilograms of cannabis annually) along with already-built consumer bases thanks to the likes of Spartan Wellness, Panaxia and Salus BioPharma. Plus, it will still maintain Canadian right to the Melting Point extract brands. All told, the merger and the spin-out company should be interesting to watch as the holiday lights come down and Q1 2019 ramps up. DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views ofequities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:https://www.equities.com/disclaimer
Comment by Mike411Ontario on Dec 29, 2018 12:40pm
I just voted FOR the MPX merger, online.  iAnthus/MPX have a bright future no doubt.  It is good to hear that MPX International is an existing business with possabilities. 
Comment by DaveInCalgary on Dec 29, 2018 12:57pm
I'm thinking of voting NO. The last license that MPX received just 2 weeks ago in Atlantic City, NJ was not even promoted by either MPX or IAN. I read about it on another companies website. I think receiving only 1/6th of an IAN share isn't really very much. Who is going to run the so called International spin off that will be left behind as IAN is not interested? Votes have to be in by ...more  
Comment by bogdansz on Dec 29, 2018 2:46pm
I`m voting NO 
Comment by RetiredGolfer on Dec 30, 2018 1:16am
Sir Scott will be running MPXI, No worries there let’s go global with MPXI. A Fresh start with a kick a$$ Brand. 
Comment by Mike411Ontario on Dec 30, 2018 3:20pm
"was not even promoted by either MPX or IAN. I read about it on another companies website." Could be in a black out period?  I would think so they have been quiet probably for good reason. The news letter that I recieve said that the new iAnthus/MPX will be a real power house.  With iAnthus they have a reputation for raising money.  MPX will need money to survive.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities